1. The use of H2 receptor antagonists to prevent hepatotoxicity induced by paracetamol overdose

   Newsletter Article 10 February 2013 Pages: 2 - 2

2. Potassium retention induced by indomethacin

   Newsletter Article 10 February 2013 Pages: 2 - 2

3. Adverse effects of drug abuse

   Newsletter Article 10 February 2013 Pages: 2 - 3

4. Postmarketing survey of the safety of cimetidine

   Newsletter Article 10 February 2013 Pages: 3 - 3

5. Carbamazepine and systemic lupus erythematosus

   Newsletter Article 10 February 2013 Pages: 3 - 3

6. Acyclovir*

   Newsletter Article 10 February 2013 Pages: 4 - 4

7. Antibacterials

   Newsletter Article 10 February 2013 Pages: 4 - 4

8. Aspirin

   Newsletter Article 10 February 2013 Pages: 4 - 4

9. Aspirin overdose

   Newsletter Article 10 February 2013 Pages: 4 - 4

10. Azathioprine

    Newsletter Article 10 February 2013 Pages: 4 - 5

11. Bismuth iodoform paraffin paste

    Newsletter Article 10 February 2013 Pages: 5 - 5

12. Captopril

    Newsletter Article 10 February 2013 Pages: 5 - 5

13. Carbamazepine

    Newsletter Article 10 February 2013 Pages: 5 - 5

14. Cefaclor/amoxycillin

    Newsletter Article 10 February 2013 Pages: 5 - 5

15. Cephalexin

    Newsletter Article 10 February 2013 Pages: 5 - 5

16. Chloroquine

    Newsletter Article 10 February 2013 Pages: 6 - 6

17. Chlorpromazine

    Newsletter Article 10 February 2013 Pages: 6 - 6

18. Cimetidine interaction see Triazolam interaction

    Newsletter Article 10 February 2013 Pages: 6 - 6

19. Cyclophosphamide interaction see Digoxin interaction

    Newsletter Article 10 February 2013 Pages: 6 - 6

20. Cyclosporin

    Newsletter Article 10 February 2013 Pages: 6 - 6

21. Cyclosporin interaction see Rifampicin interaction

    Newsletter Article 10 February 2013 Pages: 6 - 6

22. Cytostatics

    Newsletter Article 10 February 2013 Pages: 6 - 6

23. Danazol*

    Newsletter Article 10 February 2013 Pages: 6 - 7

24. Digoxin interaction

    Newsletter Article 10 February 2013 Pages: 7 - 7

25. Dlaopyramide interaction see Isosorbide dinitrate Interaction

    Newsletter Article 10 February 2013 Pages: 7 - 7

26. Doxapram hydrochloride*

    Newsletter Article 10 February 2013 Pages: 7 - 7

27. Gentamicin

    Newsletter Article 10 February 2013 Pages: 7 - 7

28. Hyoscine

    Newsletter Article 10 February 2013 Pages: 7 - 7

29. Iohexol

    Newsletter Article 10 February 2013 Pages: 7 - 8

30. Isosorbide dinitrate interaction

    Newsletter Article 10 February 2013 Pages: 8 - 8

31. Ketoprofen*

    Newsletter Article 10 February 2013 Pages: 8 - 8

32. Lithium

    Newsletter Article 10 February 2013 Pages: 8 - 8

33. Mefenamic acid

    Newsletter Article 10 February 2013 Pages: 8 - 8

34. Methylxanthines

    Newsletter Article 10 February 2013 Pages: 8 - 9

35. Minoxidil

    Newsletter Article 10 February 2013 Pages: 9 - 9

36. Oestrogen

    Newsletter Article 10 February 2013 Pages: 9 - 9

37. Pentamidine

    Newsletter Article 10 February 2013 Pages: 9 - 9

38. Quinidine

    Newsletter Article 10 February 2013 Pages: 9 - 9

39. Ranitidine

    Newsletter Article 10 February 2013 Pages: 9 - 10

40. Rifampicin interaction

    Newsletter Article 10 February 2013 Pages: 10 - 10

41. Spironolactone

    Newsletter Article 10 February 2013 Pages: 10 - 10

42. Sulindac

    Newsletter Article 10 February 2013 Pages: 10 - 10

43. Tetracycline*

    Newsletter Article 10 February 2013 Pages: 10 - 10

44. Thyroxine overdose*

    Newsletter Article 10 February 2013 Pages: 10 - 10

45. Triazolam interaction

    Newsletter Article 10 February 2013 Pages: 10 - 11

46. Side effects of cefotetan

    Newsletter Article 10 February 2013 Pages: 11 - 11

47. Adverse effects of co-trimoxazole [trimethoprim +; sulphamethoxazole]

    Newsletter Article 10 February 2013 Pages: 12 - 12

48. Drug-induced alopecia

    Newsletter Article 10 February 2013 Pages: 12 - 12